PyInvesting

Market research

ABOS Acumen Pharmaceuticals Inc

NASDAQ USD Healthcare

Latest close

0.1944 —

As of Nov 18, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
17M
P/E ratio
Not available
Analyst target
1
Dividend yield
Not available
Beta
0.45

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.

Based on the above factors, Acumen Pharmaceuticals, Inc gets an overall score of 1/5.